跳至主要内容
临床试验/NCT00004431
NCT00004431已完成不适用

Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia

University of Pittsburgh2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 1998年6月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2

研究概览

简要总结

OBJECTIVES: I. Evaluate the efficacy of L-baclofen in patients with refractory trigeminal neuralgia.

II. Evaluate the safety and tolerance of L-baclofen in these patients.

详细描述

PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled, parallel study.

Patients are randomized to receive either L-baclofen or placebo orally at increasing daily doses for 1 week. Patients then continue to receive the maximum dosage acceptable for a 1 week maintenance period.

Patients, thereafter, may enroll in a long term open label study with L-baclofen.

Patients are followed at 1, 3, 6, 9, and 12 months.

Completion date provided represents the completion date of the grant per OOPD records

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Randomized Study of L-Baclofen in Patients With... | 临床试验